Which statement correctly describes lispro (Humalog) insulin?

Enhance your geriatric care skills with our HESI Gerontology Test. Learn about age-related risks with multiple choice questions, hints, and detailed explanations to boost your exam readiness!

Multiple Choice

Which statement correctly describes lispro (Humalog) insulin?

Explanation:
Lispro is a rapid-acting insulin analog designed to match the quick rise in blood glucose that comes with a meal. Its effects begin within about 15 minutes, rise to peak in roughly 1–2 hours, and then wane over about 3–5 hours. Because of this rapid action, it’s taken right before meals (or just as you start eating) to cover post-meal glucose increases. That timing is essential—it should not be given after meals routinely, since the goal is to blunt the spike that occurs when you eat. This differs from intermediate-acting insulins, which have a slower onset and longer peaks, and from long-acting insulins that are given once or twice daily for basal coverage. Lispro does have a clear onset, so statements claiming “no onset” or “given once daily” aren’t accurate.

Lispro is a rapid-acting insulin analog designed to match the quick rise in blood glucose that comes with a meal. Its effects begin within about 15 minutes, rise to peak in roughly 1–2 hours, and then wane over about 3–5 hours. Because of this rapid action, it’s taken right before meals (or just as you start eating) to cover post-meal glucose increases. That timing is essential—it should not be given after meals routinely, since the goal is to blunt the spike that occurs when you eat.

This differs from intermediate-acting insulins, which have a slower onset and longer peaks, and from long-acting insulins that are given once or twice daily for basal coverage. Lispro does have a clear onset, so statements claiming “no onset” or “given once daily” aren’t accurate.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy